Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors

Molecular Pharmacology(2021)10.1124/molpharm.121.000402Source: DataRank Database

Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors is a research paper published in Molecular Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.02)OA: bronzeTopics (43)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Izzuddin Bin Nadzirin,Marco M. D. Cominetti,Harry Hickey,Sean A. Cullum,Mark Searcey ORCID

Live enrichment

PubMed:34718224 OpenAlex:https://openalex.org/W3211206475

British Heart Foundation

Grant: PG/16/69/32194

National Institutes of Health

Grant: 5P41GM103311-36

Resource for Biocomputing Visualization and Informatics

FWCI

2.02

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: Elsevier TDM

journalhttps://molpharm.aspetjournals.org/content/molpharm/101/1/33.full.pdf

publisherhttps://molpharm.aspetjournals.org/content/molpharm/101/1/33.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0026895X24012148?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0026895X24012148?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/molpharm.121.000402

Fields of Study

Adenosine and Purinergic SignalingPharmacological Receptor Mechanisms and EffectsReceptor Mechanisms and Signaling0301 basic medicine0303 health sciences03 medical and health sciencesAllosteric RegulationBenzodiazepinonesHEK293 CellsHumansMolecular Dynamics SimulationProtein Structure, SecondaryProtein Structure, TertiaryPurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X4

MeSH Terms

Allosteric RegulationBenzodiazepinonesHumansProtein Structure, SecondaryProtein Structure, TertiaryMolecular Dynamics SimulationHEK293 CellsReceptors, Purinergic P2X4Purinergic P2X Receptor Antagonists

Keywords

Allosteric regulationReceptorModulation (music)Allosteric modulatorChemistryComputational biologyBiochemistryBiologyPhilosophy570BenzodiazepinonesPurinergic P2X Receptor AntagonistsMolecular Dynamics SimulationProtein Structure, SecondaryProtein Structure, TertiaryHEK293 Cells615HumansReceptors, Purinergic P2X4

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being